TSE:5201Building
A Look At AGC (TSE:5201) Valuation After New Biologics Agreement And Yokohama Facility Plans
AGC stock in focus after expanded biologics agreement
AGC (TSE:5201) has come into focus after AGC Biologics expanded its manufacturing agreement with Novelty Nobility and advanced plans for a new large scale biologics facility in Yokohama, Japan.
The latest agreement extends work on a bispecific antibody drug candidate, progressing from successful cell line development in Copenhagen to process development and GMP manufacturing in Chiba, supported by AGC Biologics’ integrated global...